The fortification of various types of food with minerals is often undertaken without consideration of either their bioavailability or the potential nutrient-nutrient interactions resulting from their use. Stable isotopes provide a safe and accessible method of resolving these issues by providing the proper evidence in each case. They must be conducted according to strict safety and ethical guidelines and may be readily conducted in a field setting. Clinical studies in children enable researchers, policymakers, and food manufacturers to obtain the data necessary to determine the best way to fortify specific foods and beverages, in order to optimally enhance the nutritional health of growing children. We have shown the utility of this approach in studies in both developing countries and in the United States.
Introduction
Interventions to improve the micronutrient status of at-risk populations require specific evidence of their effectiveness. In particular, the rational provision of mineral-fortified foods to children requires accurate information regarding the bioavailability of the fortified nutrients in the target population. Currently, this information may best be determined using stable isotope techniques. Using stable isotopes allows for these assessments to be made in a completely safe and highly accurate fashion. Furthermore, stable isotope techniques are highly field-friendly, and are applicable to measurements made in both industrialized and developing countries.
In assessing bioavailability, it is crucial that the absorption of the stable isotope label closely matches that of the mineral it is tracing. This may require special dosing and batch preparation of the food to be consumed. A close collaboration among the isotope supplier, field team, and analytical team is necessary.
The benefits of fulfilling these challenging criteria are considerable. Currently, food fortification with minerals is undertaken as a national program in many developing and industrialized countries. Iron fortification of flour has become prevalent in many countries and the fortification of both beverage and flour products with calcium, zinc, and magnesium is on the rise. We will discuss two examples of the use of this technique in children. In one case, we will consider the use of stable isotopes to evaluate a potential zinc fortification program in Indonesia. In the other case, we will consider the use of stable isotopes to assess the effects of fortification of breakfast cereals with calcium.
Human use issues
An important aspect of mineral stable isotope studies is that they can be used in any subject population [1] . This includes children of all ages, as well as pregnant and lactating women. However, special considerations are involved when performing such studies in children. First, less blood generally is obtained from pediatric subjects, so special sample preparation techniques are required, as well as the use of fewer time points in kinetic analysis. Second, the rapid rate of bone turnover in adolescents mandates a greater demand for tracer, and in turn, administration of higher tracer doses to these young subjects than to adults of the same body weight [2] . Finally, analgesia during painful procedures, as well as consent and other ethical issues, must be carefully considered in performing pediatric studies.
Using stable isotopes to assess the bioavailability of minerals in food fortification programs Mineral stable isotopes have been used in thousands of clinical studies with no reported complications related to their use. Complications would only be expected related to inappropriate isotope preparation or administration, especially of intravenous doses. Because of the widespread use of isotopes in pediatric studies, we have extensively evaluated approaches to ensure maximum safety in clinical protocols.
Our foremost concern is that the isotopes be obtained from sources which have thoroughly tested and demonstrated their purity, and which provide evidence, in the form of formal certification, documenting the origin of the isotopes, the isotopic content (enrichment), and the lack of excessive trace mineral contamination (table 1) .
Unfortunately, the open distribution of mineral stable isotopes from some sources has created the potential for isotopes to be sold on the open market without these safeguards. In some cases, very low prices may serve as a red flag indicating that those isotopes were not properly obtained or distributed. Typical market prices for the most commonly used stable isotopes are provided in table 2.
An important consideration is that the phlebotomy and infusion procedures be made as painless as possible. Children have a limited ability to tolerate uncomfortable procedures, a concern which should be kept in mind when interacting with those who volunteer to participate in research studies. It should be noted that often, pediatric subjects receive no direct benefit from the study. Clearly, on principle, any potential risks and discomforts that may be associated with a child's participation in an individual study should be very carefully scrutinized and minimized.
Prior to initiation of a study, children are interviewed, and often a screening blood sample is taken. This provides an opportunity to assess whether individual subjects are sufficiently comfortable with the process of venipuncture to allow this procedure to be carried out successfully throughout the entirety of the study time period. We may choose not to enroll a subject who wishes to participate in a study because of present or foreseeable difficulties with phlebotomy.
To minimize discomfort from venipuncture, we utilize an analgesic agent for all phlebotomies. Most commonly, we use a lidocaine/prilocaine cream [eutectic mixture of local anesthetics (EMLA)] cream which has proven effective in relieving pain associated with intravenous catheter placement [3] . The universal use of EMLA cream has made participation in research studies much more acceptable to our pediatric subjects. If children express interest in a particular study, they and their parents are given complete, detailed information. A child who is old enough to independently sign a consent form may be asked to do so, based on the guidelines of the individual institution's ethical review board. Ultimately, it must be assured that the children who participate in a study understand what that study will involve and what is expected from them, within the limits of their individual cognitive capabilities. It should be emphasized to the children that their enrollment in the study is optional, and that they can either refuse to participate or leave the study after enrollment without prejudice.
The feedback from our own pediatric subjects has been overwhelmingly positive, possibly because we place a strong emphasis on making their research experience an enjoyable one. In many cases, children have used their experience as a way of learning more Prices are approximate and vary according to quantity purchased, long-term contract orders, specific form required, etc. Enrichments may vary according to the specific lot of material from which the isotopes are supplied. Some higher and lower enrichments are available for the materials listed here. Prices will vary according to the specific enrichment ordered and its availability. It is recommended that purchasers obtain, or be able to readily obtain the following documents from any distributors: » Original manufacturer's assay (must accompany the goods, with translation if needed) » A certificate of origin from the country in which the material was produced. » Third-party assay (with acceptable variation limits from the manufacturers to allow for deviation in measurement technology and quantification). » A letter from the manufacturer that states the date of manufacture, the company to which the material was sold, when it was sold, and how it was transported out of the country.
Using stable isotopes to assess the bioavailability of minerals about nutrition and science through personal involvement. Many participants' families view the research studies as a special opportunity to teach the child about nutrition and health matters, as well as the scientific process. During the studies, the children meet many dietitians, physicians, and scientists. They learn about the importance of optimal nutrition during childhood and its impact on long-term health. For example, the girls who participate in a calcium intake study focusing on osteoporosis development have an excellent opportunity to learn about the importance of consuming foods containing sufficient calcium during childhood in order to lower their risk of osteoporosis in later life. Such direct experiences demystify the scientific process for children, who often find them entertaining as well as educational.
Methodological issues
Both single-and dual-tracer methods can be utilized to conduct mineral stable isotope studies involving calcium, zinc, and magnesium [1] . A detailed review of these issues is beyond the scope of this paper. However, in general, we prefer the dual-tracer method for these minerals because it obviates the need for fecal collections. That means greater acceptability by the children who participate, as well as the potential for improved accuracy of the results. In the dual-tracer method, one isotope is given orally and a second isotope is given intravenously. Urine and serum samples are collected after the tracer dosing to determine enrichment and calculate fractional absorption. In our isotope studies, each dose of intravenously administered isotope is prepared, labeled, and dispensed by a registered pharmacist using aseptic techniques and standard protocols. All isotope infusions are performed by a physician or registered nurse. The method of oral administration depends somewhat on the specific research question being considered. For example, in calcium studies, it is common to give the tracer mixed with milk or the calcium-containing food that is being tested for calcium bioavailability. A fixed meal is usually used to maintain a constant level of the other nutrients being administered. The isotope is usually mixed into one or two servings of the food, depending on the amount of the isotope that is to be given.
The intravenous isotope may be administered in one of several ways. In studies in which frequent phlebotomy is planned related to kinetic measurements, it is necessary to place at least one intravenous access line in the subject prior to the study. The isotope may be infused either through that line or via a separate site. In most studies, especially those involving calcium or zinc, the isotope to be infused is diluted in a small amount of saline (1 to 10 ml) and given over a relatively rapid period of time, usually from 1 to 5 minutes. This approach is safe in that the amount of calcium given to children over two years of age is far below a level that would be likely to result in a measurable cardiovascular event. In infants, even smaller doses are usually given by using the least abundant calcium isotope, 46 Ca, for intravenous use.
The orally administered isotope tracer is absorbed into a central body pool, which for calcium is believed to represent serum, extracellular fluid, and some metabolically active bone. The oral tracer mixes with the intravenous (IV) tracer, which serves to "normalize" for variations in calcium distribution pool mass among subjects [4] . After administration of the tracers, a complete 24-hour urine collection is carried out. The relative fraction of the oral versus the IV tracer dose in this 24-hour urine pool is determined. This represents the fraction of the oral tracer dose that was absorbed. Because absorption is calculated from total urinary isotope recovery, it is not necessary to exactly sequence the time of administration of the oral and IV isotopes, as would be necessary if a single peak serum value were used [5] .
Although iron absorption also can be measured using a dual oral and intravenous isotope method, we generally prefer not to give iron intravenously. As 80% to 90% of newly absorbed iron is rapidly incorporated into red blood cells, a standard value can be assumed to convert red blood cell incorporation into absorption [6] . This allows the second isotope to be used in a number of different ways. Two foods can be labeled with different isotopes and given on consecutive days. The ratio of the red blood cell incorporation of the two isotopes is equal to the ratio of their absorption. Using this method, direct comparison of iron absorption from two meals can be made in a single subject from a single blood sample.
Alternatively, the second isotope can be used as a reference dose. The reference dose is an aqueous solution of ferrous sulfate with an excess of ascorbic acid, given on an empty stomach. This form allows maximum iron absorption, and is an excellent measure of iron status. As iron status is regulated by changes in absorption, the reference dose absorption is highest in subjects with the lowest iron status. The reference dose absorption can therefore be used to statistically correct for differences in iron status between subjects and increase the statistical power of the study.
When designing a mineral absorption study, an early decision is required regarding the choice of a crossover or parallel design. In a crossover design, every subject receives all the different treatments (or labeled foods) in random order. Subjects act as their own controls and, if studies are conducted relatively close together in time, the mineral status of the subjects should not change over the course of the study. This helps to reduce variability, and increases the statistical power of the study. Therefore, fewer subjects may need to be recruited.
There are, however, several problems with crossover designs. The first concern is that of an effect of the initial treatment on the results of the second study. It can often be very difficult to ascertain whether the effects of an intervention or treatment have been adequately eliminated. Use of washout periods may be beneficial, as may randomization to the initial treatment option.
In addition, there are considerable technical issues related to crossover design studies that use stable isotopes. For example, if a single measure of iron absorption is taken in a subject, then the isotopic ratio only needs to be measured at the end of the study. However, once an iron isotope is given, the red blood cells will remain enriched almost indefinitely. So if a second study is conducted, baseline enrichment must be measured. Therefore, to measure iron absorption once requires a single blood sample; to measure it twice requires three blood samples and isotope ratio measurements (two samples after the two isotope doses, and one sample before the second isotope); to measure it three times requires five samples. This procedure is particularly important for iron because its excretion is so low, and most body iron is in red blood cells. Once a calcium isotope is given, the bone (or bone and muscle, in the case of zinc) is likely to be enriched indefinitely; however, the enrichment in the plasma and urine compartment is much lower, and normally it is near baseline levels within 6 to 8 weeks. Frequently, studies can be repeated after 2 to 3 weeks if a baseline urine sample is collected.
In parallel study designs, each subject receives a single treatment. This makes the study much less intensive for the subject. However, it is possible that mineral status (or other baseline variables) may differ between groups. For this reason, larger numbers of subjects are needed for a parallel study than for a crossover study. Differences between groups can be minimized by stratified randomization. For example, in some studies of iron absorption to help ensure balance between the groups, we randomized subjects with low hemoglobin concentration separately from those with normal concentrations. Alternately, a statistical correction can be made after the study, to correct for between-group differences. In the case of iron absorption measurements, the serum ferritin can be used to correct for differences in iron status between individuals. The reference-dose iron absorption is probably even better; by using this to correct for intersubject differences in iron status, a parallel study can approach the statistical power of a crossover design.
Evaluation of food fortification in Indonesia
Food may be fortified with minerals to provide a greater supply of a nutrient, such as zinc or iron, when a dearth of that nutrient is perceived as limiting a child's growth or development. In that case, it is important to assess potential nutrient interactions, as well as the cost and optimal form of the nutrient to be delivered. These issues were evaluated in a study recently completed in collaboration with the Nutrition Research and Development Center in Bogor, Indonesia. One of the important questions weighed in this study was whether the bioavailability of zinc sulfate added as a fortificant to wheat flour would be the same as that of zinc oxide. That was a significant consideration because the oxide is potentially less expensive, but, cannot readily be used if it is not bioavailable. Furthermore, as flour in Indonesia is already iron fortified we wished to examine the effect of zinc co-fortification on iron absorption.
Recent studies have shown that zinc supplementation of high-risk populations in developing countries leads to significant decreases in mortality and morbidity from diarrhea and respiratory diseases, and may also improve growth [7] [8] [9] . This has led to the belief that sub-clinical zinc deficiency may be common in developing countries, and has sparked interest in fortifying food staples with zinc. Zinc fortification is common in industrialized countries, where the most common forms of zinc used are zinc oxide and zinc sulfate [10] . Wheat flour is generally a relatively poor source of iron and zinc (11.7 mg/kg and 7 mg/kg, respectively) [11] ; it is commonly iron-fortified throughout much of the world. In Indonesia, consideration is being given to cofortifying iron-fortified flour with zinc. However, there is concern that zinc cofortification might reduce the absorption of iron from fortified flour [12] .
Ninety healthy children (45 male and 45 female) were recruited from a rural outreach clinic in Situ Udik, a small village approximately 70 kilometers south of Jakarta, Java, Indonesia. Subjects were considered eligible for the study if they were between 4.0 and 8.0 years of age, had a height and weight greater than the third percentile for age, and had had no infectious diseases, respiratory tract infections, or diarrhea within the preceding 2 weeks. Subjects were not enrolled if they had any known chronic medical condition or were on any medications, including vitamin or mineral supplements. The nature of the study, and its potential risks and discomforts, were explained to the subject's parents by the study personnel; informed written consent was obtained from the subject's parents. The study received ethical approval from the Ethical Committee of the National Institute for Health Research and Development, Bogor, Indonesia; and from the Institutional Review Board of Baylor College of Medicine, Houston, Texas. To ensure that the results were not confounded by parasitic infections, the subjects received antihelminthic treatment with mebendazole (500 mg) as a single oral dose approximately two weeks prior to the start of the bioavailability study.
Using stable isotopes to assess the bioavailability of minerals For oral administration, we prepared 67 Zn as both 67 Zn oxide and 67 Zn sulfate. These were mixed with the steamed dough balls that consisted of the food product to be fortified. Flour sufficient to make 36 portions of 25 g each was weighed out. This excess production (approximately 20%) was set up as a safeguard in case additional subjects needed to be recruited, to allow for the loss of subjects between the time the food was consumed and the time blood and urine samples were taken. The iron and zinc isotopes were added to water, which in turn was added to the dough. The isotopes were added in this manner in an attempt to ensure even distribution of the isotope throughout the dough. The mixture was seasoned with crushed garlic, salt, and pepper, and mixed by hand for 5 to 10 minutes. More water was added slowly, to produce the desired consistency. Once a smooth, pliable dough was produced, the dough mixture was re-weighed and divided into 36 equal portions by weighing the desired amount of dough on scales. The mass of dough in each portion (1/36 of the total mass) was weighed out to within 0.1g of the desired weight. Each portion (equivalent to 25 g flour, 1.5 mg iron isotope ± 1.5 mg zinc isotope) was divided into four balls and placed in an individual steaming bag, which was steamed for 5 to 10 minutes. The bags were frozen until required for use.
For intravenous use, 70 Zn, 90% enriched, was prepared as an aqueous solution of zinc chloride by the Investigational Drug Pharmacy of Texas Children's Hospital in Houston, and tested for sterility and pyrogenicity prior to intravenous administration. Isotopes were produced in Russia and purchased from Trace Sciences, Inc., Toronto, Canada.
After an overnight fast, subjects received an intravenous infusion of 0.2 mg 70 Zn. Afterward, the subjects received a meal consisting of the steamed dough balls that were reheated immediately before they were served by steaming for approximately 5 minutes. In addition, the subjects were fed a small amount (~2 tablespoons) of a seasoned tomato puree and 100 ml of water. Subjects fasted for an additional two hours before being discharged. Approximately 48 and 72 hours after discharge, subjects collected a urine sample for zinc isotope ratio analysis.
Urinary zinc isotope ratios were measured following acid digestion and anion exchange. Twelve-ml aliquots of urine were digested with 10 ml of 15 N nitric acid overnight on a hot plate. The dried sample was dissolved in 1 ml of 6 N hydrochloric acid and loaded onto an anion exchange resin column (AG 1-X8 resin, Bio-Rad Laboratories, Hercules, Calif., USA) that had been prewashed with 10 ml of double-distilled water and 5 ml of 6 N hydrochloric acid. The column was washed with serial 5 ml aliquots of 6 N, 3 N, 2 N, 1 N, and 0.5 N hydrochloric acid, and the samples eluted with 6 ml of double distilled water. Ten µL of 0.7 N phosphoric acid were added, and the sample dried on a hot plate overnight in a Teflon vial before being re-suspended in 0.5-ml double-distilled water. Ten to 20 µL of this solution, 2 µL of 0.7 N phosphoric acid and 6 µL of silica suspension were loaded onto rhenium filaments. Isotope enrichments were measured by magnetic sector thermal ionization mass spectrometry. Isotope ratios were expressed with respect to the non-administered isotope, 66 Zn, and corrected for differences in fractionation using the 64 Zn/ 66 Zn ratio. Replicate blocks of 10 scans were performed until the desired degree of precision was obtained [13] Zinc absorption was calculated from the fractional excretion of the oral and intravenous isotopes in the 48-and 72-hour urine samples [1] . The two estimates of zinc absorption were averaged to give a final value. We found that there was no difference in zinc absorption between the children who received the zinc oxide (24.1 ± 8.2%) and those who received the zinc sulfate (23.7 ± 11.2%; p = .87). This result was somewhat unexpected. Because zinc oxide is less soluble than zinc sulfate, it has been generally expected that zinc absorption would be greater from zinc sulfate than from zinc oxide. However, there is little objective evidence to support a bioavailability difference. In fact, the small amount of preliminary evidence in humans suggests that zinc absorption is similar from zinc oxide and zinc sulfate [14] . Our data are consistent with this indication.
Iron absorption was 15.9 ± 6.8% in Group 1 (iron only), 14.0 ± 8.9% in Group 2 (iron and zinc oxide), and 11.5 ± 4.9% in Group 3 (iron and zinc sulfate), and tended to vary between the groups (ANOVA p-value = .068). Post-hoc testing (Fisher's PLSD-protected least square differences) revealed a significant difference between Group 1 (iron only) and Group 3 (iron +zinc sulfate; mean difference 4.36%, p-value = .021), but not between Group 1 (iron only) and Group 2 (iron and zinc oxide; mean difference 1.88%, p-value = .32). These data suggest that zinc sulfate, but not zinc oxide, may have an adverse effect on iron absorption. The possibility that iron can inhibit zinc absorption due to the two minerals competing for a shared absorptive pathway has been considered [15] , and is felt to be likely, as these two minerals have similar physical properties [16] . There are several possible sites of inhibition, which have been reviewed elsewhere [17] . One intriguing, possible site of interaction between iron and zinc is at the duodenal transport protein DCT-1 (divalent cation transporter -1) also known as DMT-1 (duodenal metal transporter-1) [18] . This appears to be important in iron absorption, but can also transport many other metals, including zinc [18] . If iron and zinc can inhibit one other's absorption by competition for DCT-1, the effects would be expected to be most noticeable when one metal is in relative excess compared to the other. This is consistent with the observation that iron has little effect on zinc absorption when iron:zinc ratios are 1:1, but it has an inhibitory effect on zinc absorption when ratios are 2:1 or greater [20] .
Although a number of studies have examined the effect of iron supplementation on zinc absorption, few have considered the effect of zinc supplementation on iron absorption. One study has examined the effect of zinc on radio-iron absorption from an aqueous solution [21] . Zinc had no effect on radio-iron absorption when the zinc:iron ratio was 0.36:1 (molar ratio 0.4:1), but a significant inhibition of radio-iron absorption was seen when the zinc:iron ratio was 1.14:1 (molar ratio 1:1). A second study showed that an iron:zinc ratio of 5:1 significantly reduced iron absorption from an aqueous solution, but did not affect heme iron absorption from a hamburger meal [22] . In our study, the zinc:iron ratio was 1:1, and a reduction in iron absorption was noted if zinc sulfate was the fortificant, but not if zinc oxide was. The reason for the difference between zinc oxide and zinc sulfate is not immediately clear. Zinc sulfate is, however, much more soluble in water than zinc oxide [23] , and it is possible that not all the zinc oxide dissolved in the dough. If this were the case, the zinc:iron ratio in the aqueous phase might be less than 1:1 when zinc oxide was the fortificant. At this lower ratio, zinc may have no effect on iron absorption, or the effect may be sufficiently reduced to make it undetectable with a sample size of 30 per group. In our study, iron absorption fell from 15.9 % to 14.0% when zinc oxide was added, but this was not statistically significant. If this effect were true, a sample size of 274 per group would have been required to have an 80% chance of reaching statistical significance at p < .05.
Because zinc oxide is less soluble than zinc sulfate, it has been generally expected that absorption of zinc from zinc sulfate would be superior to that from zinc oxide. There is little objective evidence to support this, and the small amount of preliminary evidence in humans suggests that zinc absorption from zinc oxide and zinc sulfate is similar [14] . Indeed, the concept that in vitro solubility is directly related to mineral absorption is untested [24] . We found no difference between zinc absorption from zinc oxide and from zinc sulfate. An alternative hypothesis, therefore, is that the zinc oxide dissolved more slowly than the zinc sulfate. Perhaps this led to a higher zinc:iron ratio in the proximal gastrointestinal tract when zinc sulfate was used as the fortificant than when zinc sulfate was used as such, leading to a significant interaction between iron and zinc sulfate, but not between iron and zinc oxide.
Because of the low levels of iron and zinc in flour, cofortification with iron and zinc oxide or zinc sulfate would lead to significantly increased absorption of both iron and zinc. However, our study was carried out in the context of existing iron fortification of flour, and the question we addressed was whether adding zinc oxide or zinc sulfate might reduce iron absorption. The results of our study suggest that co-fortification with zinc sulfate might reduce iron absorption. As zinc absorption was similar from zinc sulfate and zinc oxide, we suggest that zinc oxide might be a preferable choice, especially as it is cheaper than zinc sulfate (a significant consideration).
Iron and zinc deficiencies are huge public health issues in developing countries, and it is important that the results of a single, relatively small, study are not over-interpreted. Further studies are urgently needed to confirm or refute our preliminary findings. These studies should not only evaluate iron and zinc absorption from fortified foods, but examine the effects of prolonged consumption of fortified foods on iron and zinc status, and on mortality and morbidity. Clearly, we have much to learn about the optimum ways to fortify food staples with iron and zinc in developing countries, and the potential interactions that may result between minerals.
Calcium fortification of breakfast cereals
Fortification of commonly eaten food products is increasing worldwide, even in those regions in which malnutrition is not widespread. This may be attributed to the dual goals of preventing acute nutrient deficiencies and decreasing long-term morbidity related to micronutrient inadequacy. For example, flour is now commonly fortified with folate and iron, and salt is typically fortified with iodine. At this time, the very low dietary calcium intake of children and adolescents in the United States is a serious public health concern [25] . Dietary calcium from dairy products and other natural food sources is generally not ingested in amounts sufficient to meet current dietary recommendations. Specifically, over 80% of adolescent females do not meet the 1300 mg/day calcium intake currently recommended for 9 to 18-year-olds [26, 27] . Therefore, the fortification of food and beverages, especially breakfast cereals and fruit juice, has been widely undertaken by food manufacturers. Food labeling laws in the United States currently allow foods to be described as "good sources" of calcium if they contain 100 mg of calcium per serving. However, there is no requirement that the bioavailability of this calcium, or any other nutrient, be evaluated.
We sought to determine whether the addition of calcium to cereal would have a net positive effect on calcium absorption without decreasing iron absorption [28] . Twenty-seven US children, 6 to 9 years of age, were provided two servings per day (30 g of cereal per serving) of either a low (39 mg per serving) or fortified (156 mg per serving) calcium-containing cereal product for 14 days. Calcium absorption was measured using stable isotopes added to milk (44 Ca, extrinsically labeled) and to the calcium-fortified cereal (48 Ca, intrinsically labeled. The cereal used in this study Using stable isotopes to assess the bioavailability of minerals was Kix, a corn-puffed cereal (General Mills, Inc., Minneapolis, Minn., USA). The manufacturer supplied special batches of the cereal for use during the study, and measured servings were provided to the families during the two-week adaptation period. The cereal was calcium-fortified by adding calcium carbonate to the dry mix of the cereal prior to cooking and puffing.
The 27 children who completed the study had a mean age of 7.8 ± 1.0 years (range 6.1-9.0 years). Thirteen children were Caucasian, two were African-American, nine were Hispanic, and three were multiethnic (meaning that these three children had one Caucasian and one Hispanic parent). All of the children were prepubertal. Their mean weight was 27.7 ± 7.4 kg (range 18.0 to 43.7 kg).
The fortified cereal contained 156 mg of calcium, while the unfortified cereal contained 39 mg of calcium per 30 g serving. Thus, two servings of fortified cereal provided an additional 234 mg calcium per day compared to the unfortified product. When calculated as part of the entire diet, the calcium intake of the subjects averaged 699 ± 58 mg per day when they received unfortified cereal, and 912 ± 55 mg per day when they received fortified cereal.
The study was designed to compare the absorption of calcium from cereal with that from milk. To determine whether addition of the fortified cereal lowered milk calcium absorption, subjects were also studied when fed a low-calcium-containing cereal.
Calcium absorption from the fortified cereal was assessed using a special batch of cereal that had been labeled with 48 Ca during production. This was consumed along with 44 Ca-labeled milk with breakfast. A dose of 46 Ca was given intravenously afterwards. A second serving of 48 Ca-labeled cereal was given with lunch.
Fractional absorption of calcium from milk when given with fortified cereal was 28.9 ± 6.6% and when given with noncalcium-fortified cereal, it was 30.8 ± 6.6 (p = .17). Calcium absorption from the labeled cereal was 30.6 ± 7.8%. This value was not significantly different than the absorption of calcium from milk when given with either type of cereal (p > .2 for each comparison). Total calcium absorption (269 ± 45 vs. 215 ± 45 mg/day, p < .001) was greater in the children with a higher calcium intake.
This study demonstrated a marked nutritional benefit to prepubertal children by increasing their calcium intake via fortification of a breakfast cereal that they consumed with milk, and also as a snack. The net effect of fortifying two servings each day with a modest amount of calcium was an increase in calcium retention (balance) of 56 mg per day. This benefit, if maintained over one year, would lead to a relative increase in retention of 20 g of calcium per year, which would represent approximately 4% of a typical 500 g calcium skeleton in a child.
